Cargando…
2712. Safety and Immunogenicity of two Doses of ExPEC4V Vaccine Against Extraintestinal Pathogenic Escherichia coli Disease in Healthy Adult Participants
BACKGROUND: The ExPEC4V vaccine contains 4 Escherichia coli O-antigens (O1A, O2, O6A, O25B) conjugated to exotoxin protein A and is being studied for prevention of Invasive Extraintestinal pathogenic E. coli (ExPEC) Disease (IED). This phase-2 double-blind study assessed safety and immunogenicity of...
Autores principales: | B Smith, William, Abbanat, Darren, Spiessens, Bart, Go, Oscar, Haazen, Wouter, de Rosa, Tiziano, Fae, Kellen, Poolman, Jan, Thoelen, Stefan, de Palacios, Patricia Ibarra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810236/ http://dx.doi.org/10.1093/ofid/ofz360.2389 |
Ejemplares similares
-
Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants
por: Inoue, Megumi, et al.
Publicado: (2018) -
Identification of Risk Factors for Invasive Extraintestinal Pathogenic Escherichia coli (ExPEC) Disease
por: Clarke, Erik, et al.
Publicado: (2021) -
Genomic and Temporal Trends in Canine ExPEC Reflect Those of Human ExPEC
por: Elankumaran, Paarthiphan, et al.
Publicado: (2022) -
Repurposing Ellipticine Hydrochloride to Combat Colistin-Resistant Extraintestinal Pathogenic E. coli (ExPEC)
por: Lu, Hao, et al.
Publicado: (2020) -
Antibiotic Resistance and Virulence of Extraintestinal Pathogenic Escherichia coli (ExPEC) Vary According to Molecular Types
por: Duan, Yitao, et al.
Publicado: (2020)